Director, Global Value & Market Access

Scope of the Role

This pivotal global role within the Global Value & Market Access team is responsible for shaping global market access, pricing, evidence‑generation, and health policy strategies for Alfasigma’s specialty and rare disease portfolio. The position drives the development of compelling value propositions and evidence plans that support optimal pricing, reimbursement, and patient access outcomes across key global markets. Working in close partnership with the SVP Global Value & Market Access and cross‑functional stakeholders, the role integrates payer, Health Technology Assessment (HTA), and health policy perspectives into asset strategy and lifecycle planning.

The role offers a unique opportunity to influence asset value maximization, portfolio strategy, shape access decisions from early development through launch, and contribute to Alfasigma's leadership in rare diseases and orphan drugs.

• Define and execute global access, pricing, value, and health policy strategies.
• Develop value propositions aligned with unmet needs and business priorities.
• Integrate payer, HTA, healthcare system, and policy insights into decision‑making.
• Anticipate evolving access and policy landscapes across key markets.
• Optimize pricing, access, and sustainable patient access opportunities.

• Define evidence needs for payers, HTA bodies, and policymakers.
• Partner cross‑functionally to align evidence with access objectives.
• Lead generation of clinical, economic, real‑world, and patient‑centered evidence.
• Ensure value packages meet stakeholder needs.
• Support lifecycle strategies to strengthen access and reimbursement outcomes.

• Lead development of global value dossiers, payer tools, and access plans.
• Prepare evidence packages for HTA, reimbursement, and value communication.
• Oversee health economic and comparative effectiveness analyses.
• Support local adaptation of global tools.
• Drive market access best practices and standards.

• Embed access considerations throughout the asset lifecycle.
• Guide launch strategy, pricing, market entry, and risk management.
• Train affiliates on value communication, evidence, pricing, and HTA engagement.
• Ensure launch market access readiness.
• Align global strategy with local execution.

• Serve as a trusted expert in access, pricing, HTA, and health policy.
• Provide thought leadership on payer, HTA, and policy trends.
• Bring access and policy perspectives into strategic decisions.
• Build strong internal and external partnerships.
• Monitor trends to support portfolio strategy and growth.

• 10+ years in Global Market Access, Pricing, HTA, HEOR, or Market Access Consulting within pharma/biotech, with proven experience in developing global access, pricing, reimbursement, evidence‑generation, and value strategies across the product lifecycle, preferably in rare diseases, orphan drugs, or specialty care.
• Advanced degree in Life Sciences, Pharmacy, Medicine, Health Economics, Public Health, Health Policy, or related field; MBA, MSc, MPH, PhD, PharmD, MD, or equivalent preferred.
• Strong knowledge of global pricing, reimbursement, HTA, HEOR, payer systems, health policy, evidence generation, value proposition development, and market access strategy, including experience with HTA agencies, payers, and policymakers.
• Demonstrated ability to influence cross‑functional decision‑making, translate business objectives into access and pricing strategies, and drive results in complex global organizations.
• Excellent communication, stakeholder management, analytical, and problem‑solving skills, with the ability to build partnerships across functions, cultures, and geographies and manage multiple priorities in a fast‑paced environment.

Competitive salary, comprehensive benefits, and extensive opportunities for professional growth and development.

We value diversity and welcome individuals with unique perspectives and experiences. We believe that open‑mindedness, collaboration, and a shared passion for innovation are essential to achieving meaningful progress.